|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 1001 Pennsylvania Avenue NW |
Address2 | Suite 710 |
City | Washington |
State | DC |
Zip Code | 20004 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 6484-12
|
||||||||
|
6. House ID# 314020000
|
TYPE OF REPORT | 8. Year | 2022 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Samuel Marchio |
Date | 10/20/2022 5:36:07 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (individual mandate, cost sharing reduction subsidies, reinsurance transitional policies) ACA 1332 Waivers
Individual market and exchange stabilization
Prior authorization
Hospital Consolidation
Transparency of Hospital Billing Act (H.R.8133)
Flexibility in Hospital Ownership Act
Oversight of Anti-Competitive Behavior of Non-Profit Hospitals Act
Consumer Choice of Care Act
Competition in State Healthcare Markets Act
Addressing Anti-Competitive Contracting Clauses Act
Increasing Competition for Medical Residency Act
Privacy and Healthcare Cybersecurity
Social Determinants of Health (SDOH)
Mental health and substance use, CFR Part 2, Parity and compliance issues
H.R. 7780 - Mental Health Matters Act
Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R.7666)
Behavioral Health Crisis Intervention and 9-8-8 hotline services
Mental health parity and MHPAEA compliance
Surprise medical billing
Price of prescription drugs
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing,
Pharmacy Benefit Manager Transparency Act (S. 4293)
Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
Chronic Kidney Disease Conditions of Coverage Reform
COVID-19 testing, vaccines, treatment, cost sharing
Medicare Sequestration, ACA subsidies, COVID vaccines and testing, Consolidated Appropriations Act
Telehealth
KEEP Telehealth Options Act
Short Term Limited Duration health plans
Consolidated Appropriations Act (H.R. 133)
Medical Loss Ratio
Federal Medical Assistance Percentages (FMAP) increase
Special Enrollment Period
Hospital Claims Form Issues
Build Back Better Act (H.R.5376)
Inflation Reduction Act of 2022
Medicaid eligibility
Health Equity/Health Disparities
Defense Health Programs (FY2022 Budget and FY2023 Budget Request)
Veterans Health Care
Veterans PACT Act
Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022
Achieving Equity in the Treatment of Dual Eligible Beneficiaries Act (H.R. 7997)
TCPA
Insurance Navigators
Network Adequacy
Provider Directories
Bipartisan Safer Communities Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Samuel |
Marchio |
|
|
|
Adam |
Goldberg |
|
|
|
Catherine |
Nabavi |
|
|
|
James |
Stursberg |
|
|
|
Elizabeth |
Hall |
|
|
|
Timothy |
Drumm |
|
|
|
Simone |
Myrie |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
ACA implementation (exchange operations and functionality, risk mitigation programs, risk adjustment)
ACA reform (individual mandate, cost sharing reduction subsidies, reinsurance transitional policies) ACA 1332 Waivers
Individual market and exchange stabilization
Prior authorization
Hospital Consolidation
Transparency of Hospital Billing Act (H.R.8133)
Flexibility in Hospital Ownership Act
Oversight of Anti-Competitive Behavior of Non-Profit Hospitals Act
Consumer Choice of Care Act
Competition in State Healthcare Markets Act
Addressing Anti-Competitive Contracting Clauses Act
Increasing Competition for Medical Residency Act
Privacy and Healthcare Cybersecurity
Social Determinants of Health (SDOH)
Mental health and substance use, CFR Part 2, Parity and compliance issues
H.R. 7780 - Mental Health Matters Act
Restoring Hope for Mental Health and Well-Being Act of 2022 (H.R.7666)
Behavioral Health Crisis Intervention and 9-8-8 hotline services
Mental health parity and MHPAEA compliance
Surprise medical billing
Price of prescription drugs
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing,
Pharmacy Benefit Manager Transparency Act (S. 4293)
Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
Chronic Kidney Disease Conditions of Coverage Reform
COVID-19 testing, vaccines, treatment, cost sharing
Medicare Sequestration, ACA subsidies, COVID vaccines and testing, Consolidated Appropriations Act
Telehealth
KEEP Telehealth Options Act
Short Term Limited Duration health plans
Consolidated Appropriations Act (H.R. 133)
Medical Loss Ratio
Federal Medical Assistance Percentages (FMAP) increase
Special Enrollment Period
Hospital Claims Form Issues
Build Back Better Act (H.R.5376)
Inflation Reduction Act of 2022
Medicaid eligibility
Health Equity/Health Disparities
Defense Health Programs (FY2022 Budget and FY2023 Budget Request)
Veterans Health Care
Veterans PACT Act
Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022
Achieving Equity in the Treatment of Dual Eligible Beneficiaries Act (H.R. 7997)
TCPA
Insurance Navigators
Network Adequacy
Provider Directories
Bipartisan Safer Communities Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Samuel |
Marchio |
|
|
|
Adam |
Goldberg |
|
|
|
Catherine |
Nabavi |
|
|
|
James |
Stursberg |
|
|
|
Elizabeth |
Hall |
|
|
|
Timothy |
Drumm |
|
|
|
Simone |
Myrie |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Medicare Advantage (risk adjustment, coding intensity, encounter data, dual-eligible members, star ratings, extreme and uncontrollable circumstances policy, normalization factors, stars contract consolidation, ESRD, audio-only telehealth)
Medicare RAD-V
Mental health and substance use (42 CFR Part 2)
Medicaid managed care (IMD Exclusion)
Medicaid expansion
Medicaid reform (block grants, per capita caps)
Medicaid and CHIP reauthorization
Medicaid actuarial soundness
Long-term services and supports
Medicare Part D prescription drug program and Medicare Part D coverage gap (donut hole)
Opioid addiction issues and response (prescription drug monitoring programs)
Medicaid medical loss ratio remittance
Medicare Advantage Pilot Program in TRICARE
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing
Direct and Indirect Remuneration (DIR) reforms in the FY 2023 Medicare Part D Notice
H.R.6833 - Affordable Insulin Now Act
Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act
H.R.7666 - Restoring Hope for Mental Health and Well-Being Act of 2022
Social Determents of Health (SDOH)
H.R.4074 - Addressing Social Determinants in Medicare Advantage Act of 2021
Health Equity/Health Disparities
Maternal health (Medicaid postpartum coverage extension, H.R.959 Black Maternal Health Momnibus Act of 2021) Helping MOMS Act of 2021
Medicare Audio-Only Telehealth (H.R.2166, S.150)
Continuing Resolution (CR)FY 2022 Medicaid Funding for Puerto Rico
Medicare Savings Program (MSP) in Medicaid
Increasing on the Medicare Advantage benchmarks to a minimum level
H.R. 7997 (to Amend the SS Act to establish a floor in MA benchmark rates for regions with low Medicare fee-for-service penetration and to make the Medicare Savings Program available in all jurisdictions)
H.R. 2217 (Territory Federal Matching Requirement Equity Act of 2021)
H.R. 1825 (A Bill to Remove the Matching Requirement for Medicare Part D Drugs)
H.R. 1826 (Fairness in Medicare Part B Enrollment Act)
S. 3778 (Territories Medicare Prescription Drug Assistance Equity Act of 2022).
H.R.5376 - Build Back Better Act
Medicaid eligibility and redeterminations
H.R. 5376 - Inflation Reduction Act of 2022
Medicare Advantage Supplemental Benefits
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Samuel |
Marchio |
|
|
|
Adam |
Goldberg |
|
|
|
Catherine |
Nabavi |
|
|
|
James |
Stursberg |
|
|
|
Jonathan |
Bonet-Rivera |
|
|
|
Elizabeth |
Hall |
|
|
|
Timothy |
Drumm |
|
|
|
Simone |
Myrie |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Price of prescription drugs; antitrust issues; Prescription Drug Pricing Reduction Act
Pharmacy Benefit Manager (PBM) operations and practices, Spread pricing
Direct and Indirect Remuneration (DIR)
Drug Rebate Rule/Executive Order
Senate Finance Committee Prescription Drug Pricing Reduction Act
Lower Drug Costs Now Act (H.R. 3)
Drug Patent Reform
Robinson-Patman Reform
H.R. 5376 - Inflation Reduction Act of 2022
Pharmacy Benefit Manager Transparency Act (S. 4293)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Samuel |
Marchio |
|
|
|
Catherine |
Nabavi |
|
|
|
James |
Stursberg |
|
|
|
Adam |
Goldberg |
|
|
|
Elizabeth |
Hall |
|
|
|
Timothy |
Drumm |
|
|
|
Simone |
Myrie |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code FIN
16. Specific lobbying issues
Federal Medical Assistance Percentages (FMAP) increase
COVID-19 testing, vaccinations, cost sharing for COVID-19 testing
APTC Expansion and Permanency
CARES Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Samuel |
Marchio |
|
|
|
Adam |
Goldberg |
|
|
|
Catherine |
Nabavi |
|
|
|
James |
Stursberg |
|
|
|
Elizabeth |
Hall |
|
|
|
Timothy |
Drumm |
|
|
|
Simone |
Myrie |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |